Skip to main content
  • ASM
    • Antimicrobial Agents and Chemotherapy
    • Applied and Environmental Microbiology
    • Clinical Microbiology Reviews
    • Clinical and Vaccine Immunology
    • EcoSal Plus
    • Eukaryotic Cell
    • Infection and Immunity
    • Journal of Bacteriology
    • Journal of Clinical Microbiology
    • Journal of Microbiology & Biology Education
    • Journal of Virology
    • mBio
    • Microbiology and Molecular Biology Reviews
    • Microbiology Resource Announcements
    • Microbiology Spectrum
    • Molecular and Cellular Biology
    • mSphere
    • mSystems
  • Log in
  • My alerts
  • My Cart

Main menu

  • Home
  • Articles
    • Current Issue
    • Accepted Manuscripts
    • COVID-19 Special Collection
    • Archive
    • Minireviews
  • For Authors
    • Submit a Manuscript
    • Scope
    • Editorial Policy
    • Submission, Review, & Publication Processes
    • Organization and Format
    • Errata, Author Corrections, Retractions
    • Illustrations and Tables
    • Nomenclature
    • Abbreviations and Conventions
    • Publication Fees
    • Ethics Resources and Policies
  • About the Journal
    • About AAC
    • Editor in Chief
    • Editorial Board
    • For Reviewers
    • For the Media
    • For Librarians
    • For Advertisers
    • Alerts
    • AAC Podcast
    • RSS
    • FAQ
  • Subscribe
    • Members
    • Institutions
  • ASM
    • Antimicrobial Agents and Chemotherapy
    • Applied and Environmental Microbiology
    • Clinical Microbiology Reviews
    • Clinical and Vaccine Immunology
    • EcoSal Plus
    • Eukaryotic Cell
    • Infection and Immunity
    • Journal of Bacteriology
    • Journal of Clinical Microbiology
    • Journal of Microbiology & Biology Education
    • Journal of Virology
    • mBio
    • Microbiology and Molecular Biology Reviews
    • Microbiology Resource Announcements
    • Microbiology Spectrum
    • Molecular and Cellular Biology
    • mSphere
    • mSystems

User menu

  • Log in
  • My alerts
  • My Cart

Search

  • Advanced search
Antimicrobial Agents and Chemotherapy
publisher-logosite-logo

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Accepted Manuscripts
    • COVID-19 Special Collection
    • Archive
    • Minireviews
  • For Authors
    • Submit a Manuscript
    • Scope
    • Editorial Policy
    • Submission, Review, & Publication Processes
    • Organization and Format
    • Errata, Author Corrections, Retractions
    • Illustrations and Tables
    • Nomenclature
    • Abbreviations and Conventions
    • Publication Fees
    • Ethics Resources and Policies
  • About the Journal
    • About AAC
    • Editor in Chief
    • Editorial Board
    • For Reviewers
    • For the Media
    • For Librarians
    • For Advertisers
    • Alerts
    • AAC Podcast
    • RSS
    • FAQ
  • Subscribe
    • Members
    • Institutions
Susceptibility

A Peptide with a ProGln C Terminus in the Human Saliva Peptidome Exerts Bactericidal Activity against Propionibacterium acnes

Chun-Ming Huang, Justin W. Torpey, Yu-Tseung Liu, Yun-Ru Chen, Katherine E. Williams, Elizabeth A. Komives, Richard L. Gallo
Chun-Ming Huang
1Department of Medicine, Division of Dermatology, University of California, San Diego
2VA San Diego Healthcare Center, San Diego
3Moores Cancer Center, University of California, San Diego
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: chunming@ucsd.edu
Justin W. Torpey
4Department of Chemistry and Biochemistry, University of California, San Diego, San Diego
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Yu-Tseung Liu
3Moores Cancer Center, University of California, San Diego
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Yun-Ru Chen
1Department of Medicine, Division of Dermatology, University of California, San Diego
2VA San Diego Healthcare Center, San Diego
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Katherine E. Williams
5Applied Biosystems, Foster City, California
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Elizabeth A. Komives
4Department of Chemistry and Biochemistry, University of California, San Diego, San Diego
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Richard L. Gallo
1Department of Medicine, Division of Dermatology, University of California, San Diego
2VA San Diego Healthcare Center, San Diego
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
DOI: 10.1128/AAC.01347-07
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

ABSTRACT

Nine proline-rich peptides ending with a proline-glutamine C terminus in a salivary peptidome were sequenced by matrix-assisted laser desorption ionization time of flight time of flight tandem mass spectrometry. A GPPPQGGRPQ peptide binds gram-positive Propionibacterium acnes and considerably inhibits bacterial growth. The peptide exhibiting innate immunity may be applied for treatment of various P. acnes-associated human diseases.

Saliva has been evaluated as a diagnostic and prognostic fluid. In this study, a human saliva peptidome was characterized by matrix-assisted laser desorption ionization time of flight time of flight (MALDI-TOF-TOF). Nine proline-rich peptides ending with a proline-glutamine sequence (PQ C terminus) were sequenced (Table 1). Previous studies have shown the release of a pentapeptide, RGRPQ, from salivary proline-rich proteins upon proteolysis by oral bacteria (6). The pentapeptide behaved as an innate-immunity-like peptide, since synthetic RGRPQ was found to desorb bound bacteria (6). In addition, a synthetic GGRPQ peptide showed activity equal to that of RGRPQ, which exhibited an excellent ability to inhibit the adhesion of oral bacteria to salivary proline-rich proteins with which hydroxyapatite beads were coated (6). By searching the nine peptides with PQ C termini found in the saliva peptidome (Table 1), we found that one peptide (GPPPQGGRPQ [m/z 990.60]) contained the GGRPQ C-terminal residues (underlined). Thus, this peptide was selected for investigation of its bacterial binding and antimicrobial activities.

Whole saliva from two males and one female between the ages of 20 and 40 was collected according to protocols described previously (9). After centrifugation (14,000 × g), the clear whole-saliva supernatants (0.4 μg/μl) collected from the three volunteers were pooled, digested immediately with trypsin (20 ng/μl) overnight (20), and then mixed 1:2 with alpha-cyano-4-hydroxycinnimic acid (7 mg/ml) for analysis by liquid chromatography-MALDI-TOF-TOF mass spectrometry (MS) (4800 TOF-TOF Analyzer; Applied Biosystems, Foster City, CA) (2, 21). Sixty-three saliva peptides corresponding to 22 proteins were identified from tryptic digests (data not shown). Nine saliva peptides ending with a PQ C terminus (Table 1) were derived from basic salivary proline-rich protein 2, salivary acidic proline-rich phosphoprotein (1/2), and basic proline-rich peptide P-E (IB-9).

The GPPPQGGRPQ peptide was synthesized and labeled with fluorescein (GenScript Corp., Piscataway, NJ). The fluorescein-labeled peptide was obtained by coupling 5(6)-carboxyfluorescein to the amino terminus of GPPPQGGRPQ (10). Two gram-positive oral bacteria, Porphyromonas gingivalis (ATCC 33277) and Porphyromonas acnes (ATCC 6919) (11, 16), were chosen for interaction with GPPPQGGRPQ. Both bacteria (108 CFU) were incubated with fluorescein-labeled or unlabeled GPPPQGGRPQ (1 and 10 μM) for 1 h. The green fluorescence derived from the binding of peptides to the bacteria was detectable only when fluorescein-labeled peptide was incubated with P. acnes (Fig. 1), but not P. gingivalis (Fig. 1F), indicating that GPPPQGGRPQ selectively adhered to P. acnes. The green fluorescence was visible when P. acnes was incubated with 1 μM (Fig. 1C) or 10 μM (Fig. 1D) of fluorescein-labeled GPPPQGGRPQ, but not unlabeled GPPPQGGRPQ (Fig. 1A) and a fluorescein-labeled CGKRK (10 μM) (Fig. 1B) (a gift from Zhang Lianglin, Moores Cancer Center at the University of California, San Diego). Notably, the green fluorescence generated by 1 μM of fluorescein-labeled peptide was entirely quenched (Fig. 1E) when 1 mM of the unlabeled GPPPQGGRPQ was present in the reaction mixture of fluorescein-labeled peptide with P. acnes, indicating that the binding of GPPPQGGRPQ to P. acnes is peptide specific.

We next examined if the GPPPQGGRPQ peptide influences the growth of P. acnes. P. acnes (105 CFU) was preincubated with phosphate-buffered saline (PBS) (Fig. 2A) or GPPPQGGRPQ at concentrations of 1 μM (Fig. 2C), 10 μM (Fig. 2D), and 100 μM (Fig. 2E) for 3 h. Preincubation of P. acnes with an antibiotic mixture (500 units/ml of penicillin G and 0.5 mg/ml of streptomycin sulfate) for 3 h significantly inhibited the 2-day growth of P. acnes (2.1 × 103 ± 6.3 × 103 CFU) in comparison with that after incubation of P. acnes with PBS (20.5 × 105 ± 2.5 × 105 CFU) (Fig. 2B and F). Treatment of P. acnes with 1, 10, and 100 μM of GPPPQGGRPQ considerably attenuated the colonization (Fig. 2C to E) and the growth (26.5 × 104 ± 6.3 × 104, 18 × 103 ± 2.6 × 103, and 9.5 × 102 ± 2.1 × 102 CFU, respectively) of P. acnes. These results demonstrated that the GPPPQGGRPQ peptide exerts a bactericidal activity against P. acnes.

Although we failed to identify low-abundance proteins, such as cytokines and defensins, that normally are considerably elevated during oral inflammation (15), an advanced electrospray ionization tandem MS with higher sensitivity may make it possible to identify lower-abundance saliva proteins (7). Since the intensity of each peptide signal in an MS spectrum does not necessarily correlate with its biological abundance, quantitative MS using isotopic-tag labeling (19) will provide a means to determine the differential abundances of peptides under different biological conditions. Although it is unclear if the GPPPQGGRPQ peptide is derived from fragmentation of bacterium-bound proline-rich proteins, it has been documented that proline-rich proteins can be cleaved by proteases from oral Streptococcus and Actinomyces species and converted into peptides with bacterium-binding PQ C termini (13). Intriguingly, several peptides with PQ C termini were identified in undigested human parotid saliva (8), suggesting that peptides with PQ C termini may exist naturally in human whole saliva. When oral bacteria predominate, these peptides with PQ C termini may serve as innate-immunity-like peptides (5, 13) to bind and/or kill oral bacteria instantly. The PQ-rich repeats also exist in other proteins, such as diacylglycerol kinase, an enzyme involved in the regulation of signal transduction (18). It has also been reported that peptides with polyprolyl or polyglutamine sequences could contribute to amyloidogenic diseases (14) and display the activity of cellular permeation, as well as binding to heat shock proteins (1). Thus, peptides with PQ C termini in saliva may have biological functions other than acting as antimicrobials.

Although the target molecules of the GPPPQGGRPQ peptide in P. acnes are undetermined, it has been documented that an RGRPQ peptide could be similar to the ERGMT peptide signal that affects intra- or extracellular receptors and gene expression in Bacillus subtilis (12). Future studies will include determining the eukaryotic toxicity and MICs of the GPPPQGGRPQ peptide against P. acnes. The complete genome of P. acnes has been sequenced (3, 4). P. acnes is involved in many infectious diseases, including acne vulgaris and biofilm formation on implanted biomaterials (17). Therefore, the future applications of the GPPPQGGRPQ peptide may include monitoring of the distribution of P. acnes and/or treatment of P. acnes-associated diseases by inhibiting bacterial growth.

FIG. 1.
  • Open in new tab
  • Download powerpoint
FIG. 1.

Fluorescence microscopic images of P. acnes upon incubation with a fluorescein-labeled GPPPQGGRPQ peptide. P. acnes was suspended in a phosphate buffer containing 1.1 mM NaH2PO4, 1 mM NaH2PO4, and 100 mM NaCl, pH 6.5, and incubated with GPPPQGGRPQ (10 μM) (A), fluorescein-labeled CGKRK (10 μM) (B), or fluorescein-labeled GPPPQGGRPQ (1 μM [C] and 10 μM [D and E]) for 1 h at 37°C under anaerobic conditions. Incubation of fluorescein-labeled CGKRK was performed to exclude nonspecific binding. (F) P. gingivalis incubated with fluorescein-labeled GPPPQGGRPQ (10 μM). The green fluorescence (arrows) indicated that fluorescein-labeled peptide bound to P. acnes. (E) The green fluorescence was entirely quenched when a high concentration (1 mM) of unlabeled GPPPQGGRPQ was added to the incubation of fluorescein-labeled peptide (1 μM) with bacteria. Bar, 1 μm.

FIG. 2.
  • Open in new tab
  • Download powerpoint
FIG. 2.

The GPPPQGGRPQ peptide suppresses the growth of P. acnes. P. acnes (1 × 105 CFU) was incubated with PBS (A), antibiotics (B), and GPPPQGGRPQ at final concentrations of 1 μM (C), 10 μM (D), and 100 μM (E) for 3 h. After a 2-day incubation, bacteria were spotted on agar plates for colonization. Bacteria incubated with peptide were spotted in duplicate (C to E). (F) The activity of the GPPPQGGRPQ peptide in bacterial growth was determined by plating serial dilutions (104 to 107) of bacteria on agar plates and quantifying the CFU. Bar, 0.5 mm. The bars represent means ± standard errors for three separate experiments. The numbers of P. acnes bacteria treated with antibiotics (hatched bar) and peptide (solid bars) were compared with that of P. acnes treated with PBS (open bar). Student's t test was conducted for comparison. P values of <0.01 (*) and <0.005 (**) were considered significant.

View this table:
  • View inline
  • View popup
TABLE 1.

Peptide PQ C termini detected in MALDI-TOF-TOF

ACKNOWLEDGMENTS

This work was supported by National Institutes of Health Grants (1-R01 AI067395, R21-R022754-01, and R21-I58002-01), a Dermatology Foundation Grant, and a SERCEB grant (5 U54 AI057157-02).

We thank M. Kirk and S. Barnes for their assistance with MS.

FOOTNOTES

    • Received 18 October 2007.
    • Returned for modification 3 January 2008.
    • Accepted 11 February 2008.
  • Copyright © 2008 American Society for Microbiology

REFERENCES

  1. 1.↵
    Bertoncini, C. W., R. M. Rasia, G. R. Lamberto, A. Binolfi, M. Zweckstetter, C. Griesinger, and C. O. Fernandez. 2007. Structural characterization of the intrinsically unfolded protein beta-synuclein, a natural negative regulator of alpha-synuclein aggregation. J. Mol. Biol.372:708-722.
    OpenUrlCrossRefPubMedWeb of Science
  2. 2.↵
    Bodnar, W. M., P. K. Blackburn, J. M. Krise, and M. A. Moseley. 2003. Exploiting the complementary nature of LC/MALDI/MS/MS and LC/ESI/MS/MS for increased proteome coverage. J. Am. Soc. Mass Spectrom.14:971-979.
    OpenUrlCrossRefPubMed
  3. 3.↵
    Bruggemann, H., A. Henne, F. Hoster, H. Liesegang, A. Wiezer, A. Strittmatter, S. Hujer, P. Durre, and G. Gottschalk. 2004. The complete genome sequence of Propionibacterium acnes, a commensal of human skin. Science305:671-673.
    OpenUrlAbstract/FREE Full Text
  4. 4.↵
    Bruggemann, H. 2005. Insights in the pathogenic potential of Propionibacterium acnes from its complete genome. Semin. Cutan. Med. Surg.24:67-72.
    OpenUrlCrossRefPubMed
  5. 5.↵
    Davtyan, T. K., H. A. Manukyan, N. R. Mkrtchyan, S. A. Avetisyan, and A. A. Galoyan. 2005. Hypothalamic proline-rich polypeptide is a regulator of oxidative burst in human neutrophils and monocytes. Neuroimmunomodulation12:270-284.
    OpenUrlPubMed
  6. 6.↵
    Drobni, M., T. Li, C. Kruger, V. Loimaranta, M. Kilian, L. Hammarström, H. J. Örnvall, T. Bergman, and N. Strömberg. 2006. Host-derived pentapeptide affecting adhesion, proliferation, and local pH in biofilm communities composed of Streptococcus and Actinomyces species. Infect. Immun.74:6293-6299.
    OpenUrlAbstract/FREE Full Text
  7. 7.↵
    Goebel, C., L. G. Mackay, E. R. Vickers, and L. E. Mather. 2000. Determination of defensin HNP-1, HNP-2, and HNP-3 in human saliva by using LC/MS. Peptides21:757-765.
    OpenUrlCrossRefPubMedWeb of Science
  8. 8.↵
    Hardt, M., L. R. Thomas, S. E. Dixon, G. Newport, N. Agabian, A. Prakobphol, S. C. Hall, H. E. Witkowska, and S. J. Fisher. 2005. Toward defining the human parotid gland salivary proteome and peptidome: identification and characterization using 2D SDS-PAGE, ultrafiltration, HPLC, and mass spectrometry. Biochemistry44:2885-2899.
    OpenUrlCrossRefPubMedWeb of Science
  9. 9.↵
    Huang, C. M. 2004. Comparative proteomic analysis of human whole saliva. Arch. Oral Biol.49:951-962.
    OpenUrlCrossRefPubMedWeb of Science
  10. 10.↵
    Huang, C. M., Y. T. Wu, and S. T. Chen. 2000. Targeting delivery of paclitaxel into tumor cells via somatostatin receptor endocytosis. Chem. Biol.7:453-461.
    OpenUrlCrossRefPubMed
  11. 11.↵
    Kataoka, K., A. Amano, M. Kuboniwa, H. Horie, H. Nagata, and S. Shizukuishi. 1997. Active sites of salivary proline-rich protein for binding to Porphyromonas gingivalis fimbriae. Infect. Immun.65:3159-3164.
    OpenUrlAbstract/FREE Full Text
  12. 12.↵
    Lazazzera, B. A., and A. D. Grossman. 1998. The ins and outs of peptide signaling. Trends Microbiol.6:288-294.
    OpenUrlCrossRefPubMedWeb of Science
  13. 13.↵
    Li, T., P. Bratt, A. P. Jonsson, M. Ryberg, I. Johansson, W. J. Griffiths, T. Bergman, and N. Stromberg. 2000. Possible release of an Arg Gly Arg Pro Gln pentapeptide with innate immunity properties from acidic proline-rich proteins by proteolytic activity in commensal Streptococcus and Actinomyces species. Infect. Immun.68:5425-5429.
    OpenUrlAbstract/FREE Full Text
  14. 14.↵
    Markossian, K. A., A. A. Zamyatnin, and B. I. Kurganov. 2004. Antibacterial proline-rich oligopeptides and their target proteins. Biochemistry69:1082-1091.
    OpenUrlPubMed
  15. 15.↵
    Mizukawa, N., K. Sugiyama, T. Ueno, K. Mishima, S. Takagi, and T. Sugahara. 1999. Levels of human defensin-1, an antimicrobial peptide, in saliva of patients with oral inflammation. Oral. Surg. Oral. Med. Oral. Pathol. Oral. Radiol. Endod.87:539-543.
    OpenUrlCrossRefPubMedWeb of Science
  16. 16.↵
    Oh, S., S. H. Kim, Y. Ko, J. H. Sim, K. S. Kim, S. H. Lee, S. Park, and Y. J. Kim. 2006. Effect of bacteriocin produced by Lactococcus sp. HY 449 on skin-inflammatory bacteria. Food Chem. Toxicol.44:1184-1190.
    OpenUrlCrossRefPubMed
  17. 17.↵
    Perry, A. L., and P. A. Lambert. 2006. Propionibacterium acnes. Lett. Appl. Microbiol.42:185-188.
    OpenUrlCrossRefPubMedWeb of Science
  18. 18.↵
    Sakane, F., and H. Kanoh. 1997. Molecules in focus: diacylglycerol kinase. Int. J. Biochem. Cell Biol.29:1139-1143.
    OpenUrlCrossRefPubMedWeb of Science
  19. 19.↵
    Shi, Y., C. A. Elmets, J. W. Smith, Y. T. Liu, Y. R. Chen, C. P. Huang, W. Zhu, H. N. Ananthaswamy, R. L. Gallo, and C. M. Huang.. Quantitative proteomes and in vivo secretomes of progressive and regressive UV-induced fibrosarcoma tumor cells: mimicking tumor microenvironment using a dermis-based cell-trapped system linked to tissue chamber. Proteomics27:4589-4600.
  20. 20.↵
    Spahr, C. S., M. T. Davis, M. D. McGinley, J. H. Robinson, E. J. Bures, J. Beierle, J. Mort, P. L. Courchesne, K. Chen, R. C. Wahl, W. Yu, R. Luethy, and S. D. Patterson. 2001. Towards defining the urinary proteome using liquid chromatography-tandem mass spectrometry. I. Profiling an unfractionated tryptic digest. Proteomics1:93-107.
    OpenUrlCrossRefPubMedWeb of Science
  21. 21.↵
    Vitorino, R., M. J. Lobo, A. J. Ferrer-Correira, J. R. Dubin, K. B. Tomer, P. M. Domingues, and F. M. Amado. 2004. Identification of human whole saliva protein components using proteomics. Proteomics4:109-115.
    OpenUrl
PreviousNext
Back to top
Download PDF
Citation Tools
A Peptide with a ProGln C Terminus in the Human Saliva Peptidome Exerts Bactericidal Activity against Propionibacterium acnes
Chun-Ming Huang, Justin W. Torpey, Yu-Tseung Liu, Yun-Ru Chen, Katherine E. Williams, Elizabeth A. Komives, Richard L. Gallo
Antimicrobial Agents and Chemotherapy Apr 2008, 52 (5) 1834-1836; DOI: 10.1128/AAC.01347-07

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Print

Alerts
Sign In to Email Alerts with your Email Address
Email

Thank you for sharing this Antimicrobial Agents and Chemotherapy article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
A Peptide with a ProGln C Terminus in the Human Saliva Peptidome Exerts Bactericidal Activity against Propionibacterium acnes
(Your Name) has forwarded a page to you from Antimicrobial Agents and Chemotherapy
(Your Name) thought you would be interested in this article in Antimicrobial Agents and Chemotherapy.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
A Peptide with a ProGln C Terminus in the Human Saliva Peptidome Exerts Bactericidal Activity against Propionibacterium acnes
Chun-Ming Huang, Justin W. Torpey, Yu-Tseung Liu, Yun-Ru Chen, Katherine E. Williams, Elizabeth A. Komives, Richard L. Gallo
Antimicrobial Agents and Chemotherapy Apr 2008, 52 (5) 1834-1836; DOI: 10.1128/AAC.01347-07
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Top
  • Article
    • ABSTRACT
    • ACKNOWLEDGMENTS
    • FOOTNOTES
    • REFERENCES
  • Figures & Data
  • Info & Metrics
  • PDF

KEYWORDS

peptides
Propionibacterium acnes
saliva
Salivary Proteins and Peptides

Related Articles

Cited By...

About

  • About AAC
  • Editor in Chief
  • Editorial Board
  • Policies
  • For Reviewers
  • For the Media
  • For Librarians
  • For Advertisers
  • Alerts
  • AAC Podcast
  • RSS
  • FAQ
  • Permissions
  • Journal Announcements

Authors

  • ASM Author Center
  • Submit a Manuscript
  • Article Types
  • Ethics
  • Contact Us

Follow #AACJournal

@ASMicrobiology

       

ASM Journals

ASM journals are the most prominent publications in the field, delivering up-to-date and authoritative coverage of both basic and clinical microbiology.

About ASM | Contact Us | Press Room

 

ASM is a member of

Scientific Society Publisher Alliance

 

American Society for Microbiology
1752 N St. NW
Washington, DC 20036
Phone: (202) 737-3600

Copyright © 2021 American Society for Microbiology | Privacy Policy | Website feedback

Print ISSN: 0066-4804; Online ISSN: 1098-6596